B-cell Lymphoid Malignancies
📧 Sign up to get email alerts when something new happens for B-cell Lymphoid Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Phase 1 Study of ESG206 in Adult Subjects With B-cell Lymphoid Malignancies [Phase 1]
A Phase 1 trial of ESG206 in adults with B-cell lymphoid malignancies has completed. The study status indicates completion with safety and e…
-
CLINICAL_TRIALS withdrawal · 2025-09-12Clinical Trial Update: A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies [Phase 1]
This update states that the first-in-human Phase I study of ESG206 in B-cell lymphoid malignancies has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 study assessing safety and pharmacokinetics of BGB-3111 in subjects with B-cell lymphoid malignancies completed; results posted in…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies [Phase 1]
Phase 1 trial update reporting results for BGB-3111 (zanubrutinib) in combination with obinutuzumab in participants with B-cell lymphoid mal…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013) [EARLY_Phase 1]
Phase 0/1 biomarker and pharmacodynamic study of roflumilast in patients with advanced B-cell lymphoid malignancies has completed, with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.